M57I (p.Met57Ile) variant of DRD2 (D(2) dopamine receptor)
M57I (p.Met57Ile) in DRD2 (D(2) dopamine receptor) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
M57I (p.Met57Ile) variant details
- p.Met57Ile
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.04
- MetaSVM -1.08
- SIFT 0.96
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available